118 related articles for article (PubMed ID: 10956256)
1. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure.
Luchner A; Jougasaki M; Friedrich E; Borgeson DD; Stevens TL; Redfield MM; Riegger GA; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R974-9. PubMed ID: 10956256
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF.
Kjekshus H; Smiseth OA; Klinge R; Oie E; Hystad ME; Attramadal H
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1299-310. PubMed ID: 10749728
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary endothelinergic system in experimental congestive heart failure.
Lepailleur-Enouf D; Egidy G; Philippe M; Louedec L; Henry J; Mulder P; Michel J
Cardiovasc Res; 2001 Feb; 49(2):330-9. PubMed ID: 11164843
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
5. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
6. Atrial and pulmonary endothelin mRNA is increased in a canine model of chronic low cardiac output.
Wei CM; Clavell AL; Burnett JC
Am J Physiol; 1997 Aug; 273(2 Pt 2):R838-44. PubMed ID: 9277577
[TBL] [Abstract][Full Text] [Related]
7. Early activation of cardiac and renal endothelin systems in experimental heart failure.
Motte S; van Beneden R; Mottet J; Rondelet B; Mathieu M; Havaux X; Lause P; Clercx C; Ketelslegers JM; Naeije R; McEntee K
Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2482-91. PubMed ID: 14613913
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary and cardiac expression of preproendothelin-1 mRNA are increased in heart failure after myocardial infarction in rats. Localization of preproendothelin-1 mRNA and endothelin peptide.
Tønnessen T; Lunde PK; Giaid A; Sejersted OM; Christensen G
Cardiovasc Res; 1998 Sep; 39(3):633-43. PubMed ID: 9861306
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 in heart and pulmonary tissue in experimental heart failure.
Sirviö ML; Helin K; Stewen P; Tikkanen I; Fyhrquist F
Blood Press; 1997 Jul; 6(4):250-5. PubMed ID: 9296313
[TBL] [Abstract][Full Text] [Related]
10. The functional shift of endothelin receptor subtypes in dogs with heart failure produced by rapid ventricular pacing.
Tadano K; Hosokawa A; Fukuroda T; Nishikibe M
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S350-3. PubMed ID: 15838318
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin in experimental congestive heart failure: cardiorenal activation.
Jougasaki M; Stevens TL; Borgeson DD; Luchner A; Redfield MM; Burnett JC
Am J Physiol; 1997 Oct; 273(4):R1392-9. PubMed ID: 9362304
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.
Sakai S; Miyauchi T; Sakurai T; Yamaguchi I; Kobayashi M; Goto K; Sugishita Y
J Am Coll Cardiol; 1996 Nov; 28(6):1580-8. PubMed ID: 8917275
[TBL] [Abstract][Full Text] [Related]
13. Increased cardiac and pulmonary endothelin-1 mRNA expression in canine pacing-induced heart failure.
Huntington K; Picard P; Moe G; Stewart DJ; Albernaz A; Monge JC
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S424-6. PubMed ID: 9595502
[TBL] [Abstract][Full Text] [Related]
14. Endothelin in human congestive heart failure.
Wei CM; Lerman A; Rodeheffer RJ; McGregor CG; Brandt RR; Wright S; Heublein DM; Kao PC; Edwards WD; Burnett JC
Circulation; 1994 Apr; 89(4):1580-6. PubMed ID: 8149524
[TBL] [Abstract][Full Text] [Related]
15. Cardiac endothelin-like immunoreactivity and preproendothelin-1 mRNA expression in human heart failure.
Tønnessen T; Lyberg T; Geiran O; Christensen G
Scand Cardiovasc J; 2000; 34(1):21-7. PubMed ID: 10816056
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure.
Iwanaga Y; Kihara Y; Inagaki K; Onozawa Y; Yoneda T; Kataoka K; Sasayama S
Circulation; 2001 Jul; 104(5):606-12. PubMed ID: 11479261
[TBL] [Abstract][Full Text] [Related]
17. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.
Sakai S; Miyauchi T; Sakurai T; Kasuya Y; Ihara M; Yamaguchi I; Goto K; Sugishita Y
Circulation; 1996 Mar; 93(6):1214-22. PubMed ID: 8653844
[TBL] [Abstract][Full Text] [Related]
18. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
[TBL] [Abstract][Full Text] [Related]
19. Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure.
Dupuis J; Moe GW; Cernacek P
Cardiovasc Res; 1998 Sep; 39(3):609-16. PubMed ID: 9861303
[TBL] [Abstract][Full Text] [Related]
20. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.
Luchner A; Stevens TL; Borgeson DD; Redfield M; Wei CM; Porter JG; Burnett JC
Am J Physiol; 1998 May; 274(5):H1684-9. PubMed ID: 9612380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
